The National Community Pharmacists Association (NPCA) is warning the feds that independent pharmacists are likely to face ...

Pharmacy Benefit Managers (PBM) sit in the center of our prescription drug system, coordinating between insurance companies, ...

The Journalist's Resource and Econofact recently hosted a webinar on covering tariffs. Watch the recording and read key ...

ALI MOJIBI Partner Covington & Burling LLP Ali Mojibi is a dynamic trial lawyer who has tried cases for leading global ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.

City attorneys allege major Pharmacy Benefit Managers (PBMs) and insulin manufacturers are conspiring to artificially inflate ...

The report shows that PBMs made over $7.3 billion in extra profits from dispensing specialty generic drugs during the study ...

The NCPA has submitted comments to CMS warning that more than 90% of independent pharmacies may decide, or have already decided, not to stock drugs in the Medicare Drug Price Negotiation Program due t ...

As the rising cost of insulin continues to make it difficult for so many diabetic patients to receive life-saving care, ...

Sen. James Lankford has been trying to pass legislation in response to an industry he believes will leave small towns without ...

Oklahoma's attorney general has accused CVS's Caremark pharmacy benefit manager unit of under-reimbursing pharmacies for ...